Cell line studies of glioblastoma and malignant glioma using a newly discovered prenylated chalcone

Pharmaceutical Biology

Volumn 49, Issue 3, 2011, Pages 314-318

  Teng, Chih Chuan ^a   Sze, Chun I ^a   Wang, Ting Chung ^b   Lien, Ching Yi ^c   Liao, Wayne C ^d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

cell line study; glioblastoma; malignant gliomas; prenylated chalcones; Response surface methodology

Indexed keywords

CHALCONE DERIVATIVE; UNCLASSIFIED DRUG; WJ 9708011;

ARTICLE; CANCER CELL; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; RESPONSE SURFACE METHOD;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; CHALCONE; FLAVANONES; GLIOBLASTOMA; GLIOMA; PRENYLATION;

EID: 79951764531     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2010.515596     Document Type: Article

References (12)

1. Bas D, Boyaci IH. (2007). Modeling and optimization I: Usability of response surface methodology. J Food Eng, 78, 836-845.
2. Cacace JE, Mazza G. (2006). Optimization of extraction of anthocyanins from black currants with aqueous ethanol. J Food Sci, 68, 240-248. (Pubitemid 36238233)
3. Chang YN, Huang JC, Lee CC, Shih IL, Tzeng YM. (2002). Use of response surface methodology to optimize culture medium for production of lovastatin by Monascus rubber. Enzyme Microb Tech, 30, 889-894.
4. Dimmock JR, Elias DW, Beazely MA, Kandepu NM. (1999). Bioactivities of chalcones. Curr Med Chem, 6, 1125-1149.
5. Go ML, Wu X, Liu XL. (2005). Chalcones: An update on cytotoxic and chemoprotective properties. Curr Med Chem, 12, 481-499.
6. Huang WJ, Huang CH, Wu CL, Lin JK, Chen YW, Lin CL, Chuang SE, Huang CY, Chen CN. (2007). Propolin G, a prenylflavanone, isolated from Taiwanese propolis, induces caspase-dependent apoptosis in brain cancer cells. J Agric Food Chem, 55, 7366-7376.
7. Kanadaswami C, Lee LT, Lee PPH, Wang JJH, Ke FC, Huang YT, Lee MT. (2005). The antitumor activities of flavonoids. In Vivo, 19, 895-909.
8. Kondratyuk TP, Pezzuto JM. (2004). Natural product polyphenols of relevance to human health. Pharm Biol, 42, 46-63. (Pubitemid 40093209)
9. Liu HL, Jiang WB, Xie MX. (2010). Flavonoids: Recent advances as anticancer drugs. Recent Pat Anticancer Drug Discov, 5, 152-164.
10. Middleton E. (1996). Biological properties of plant flavonoids: An overview. Pharm Biol, 34, 344-348. (Pubitemid 27180221)
11. Ohgaki H, Kleihues P. (2005). Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol, 64, 479-489. (Pubitemid 40781150)
12. Ren W, Qiao Z, Wang H, Zhu L, Zhang L. (2003). Flavonoids: Promising anticancer agents. Med Res Rev, 23, 519-534. (Pubitemid 36706514)